Please use this identifier to cite or link to this item:
http://hdl.handle.net/10553/47273
Title: | Microsatellite instability and ploidy status define three categories with distinctive prognostic impact in endometrioid endometrial cancer | Authors: | Bilbao-Sieyro, Cristina Ramírez-Moreno, Raquel Rodríguez-González, Germán Falcón, Orlando León, Laureano Torres, Santiago Fernández, Leandro Alonso, Sergio Díaz-Chico, Nicolás Perucho, Manuel Diaz-Chico, Juan Carlos |
UNESCO Clasification: | 32 Ciencias médicas 320101 Oncología |
Keywords: | Adenomatous-Polyposis-Coli Dna Mismatch Repair Colorectal-Cancer Promoter Hypermethylation Carcinoma, et al |
Issue Date: | 2014 | Journal: | Oncotarget | Abstract: | Microsatellite instability (MSI) and aneuploidy are inversely related phenomena. We tested whether ploidy status influences the clinical impact of MSI in endometrioid endometrial cancer (EEC). We analyzed 167 EECs for MSI and ploidy. Tumors were classified in three categories according to MSI and ploidy status. Associations with clinicopathological and molecular variables, survival, and treatment response were assessed.All MSI tumors (23%) were scored as diploid, and 14% of microsatellite stable (MSS) tumors presented aneuploidy. MSI tumors associated with older age at diagnosis, non-obesity, high histological grade, and advanced surgical stage. MSS-aneuploid tumors also associated with higher grade and advanced stage. In multivariate survival analysis MSI did not influence disease-free survival (DFS) or cancer-specific survival (CSS). However, when just diploid tumors were considered for the analysis, MSI significantly contributed to worse DFS and CSS, and the same was observed for aneuploidy when MSS tumors were analyzed alone. In diploid tumors, a differential response to postoperative radiotherapy (RT) was observed according to MSI, since it predicted poor DFS and CSS in the multivariate analysis.We conclude that ploidy status influences the clinical impact of MSI in EEC. Among diploid tumors those with MSI have poor clinical outcome and respond worse to RT. | URI: | http://hdl.handle.net/10553/47273 | ISSN: | 1949-2553 | DOI: | 10.18632/oncotarget.2187 | Source: | Oncotarget[ISSN 1949-2553],v. 5 (15), p. 6206-6217 |
Appears in Collections: | Artículos |
SCOPUSTM
Citations
13
checked on Dec 1, 2024
WEB OF SCIENCETM
Citations
12
checked on Nov 24, 2024
Page view(s)
118
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Share
Export metadata
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.